Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights-Reference-Cited by-同舟云学术

Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights

Published:2024-09-03 Issue: Volume: Page:1-8
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Muradashvili Tinatin¹^ORCID,Liu Yuxin²,VanOudenhove Jennifer³,Gu Sean X.⁴,Krause Diane S.⁴⁵⁶,Montanari Francesca³,Carlino Maximillian J.⁴⁶,Mancuso Rubia⁴⁶,Stempel Jessica M.³,Halene Stephanie³^ORCID,Zeidan Amer M.³^ORCID,Podoltsev Nikolai A.³,Neparidze Natalia³

Affiliation:

1. Department of Internal Medicine, Yale School of Medicine, Waterbury, CT, USA

2. Section of Hematology, Department of Internal Medicine, Dana-Farber Cancer Institute, Boston, MA, USA

3. Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA

4. Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA

5. Department of Pathology, Yale School of Medicine, New Haven, USA

6. Yale Stem Cell Center, New Haven, CT, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2393260

Reference38 articles.

1. Surveillance Research Program. National Cancer Institute SEER*Stat software (seer.cancer.gov/seerstat) version <8.3.1>.

2. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

3. A patient with myeloma who still has pure red cell aplasia despite the most intensive immune modulation

4. Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab

5. Autoimmune Neutropenia in Multiple Myeloma and the Role of Clonal T-Cell Expansion: Evidence of Cross-Talk Between B-Cell and T-Cell Lineages?